Skip to main content
Signal8

Avacta Group Plc (AVCTF)

Avacta Group Plc, a biopharmaceutical enterprise operating at the clinical stage, was established in 2003 and is headquartered in Wetherby, UK. The company specializes in the creation of cancer treatments and diagnostic solutions, leveraging its distinctive Affimer and pre|CISION proprietary platforms. Its operations span the United Kingdom, North America, South Korea, and broader regions of Asia and Europe, structured into two main divisions: Diagnostics and Therapeutics. The Diagnostics division is responsible for developing customized Affimer proteins for both external clients and its own diagnostic assays. This segment also manufactures the AffiDX SARS-CoV-2 rapid antigen lateral flow tests and supplies Affimer reagents for integration into other companies' products. Concurrently, the Therapeutics division focuses on advancing innovative cancer immunotherapies, strategically combining Avacta's proprietary technologies. Avacta has forged a variety of key partnerships and collaborations. These include a research alliance concerning its pre|CISION technology, which utilizes a substrate engineered for cleavage by fibroblast activation protein alpha; a drug development collaboration with LG Chem Life Sciences; a joint venture with Tufts University School of Medicine to progress Affimer drug conjugate therapies; a licensing deal with POINT Biopharma Inc. for the development of tumour-activated radiopharmaceuticals; and a drug development alliance with AffyXell to engineer mesenchymal stem cells for the treatment of autoimmune diseases.

Sector: Biotechnology

Industry: Biotechnology

Avacta Group Plc logo

Avacta Group Plc

OTC:AVCTFHealthcare
CLOSED
Mkt Cap-
EV-
Float406.29M
O/S486.79M
VOL20K sh
$ Vol$15K
RVOL1.98×
Inst Own-
SI0.1%
Net Cash/Sh-
Dilution
Short interest (FINRA)
0.1%
Oct 30 (18d)

Float 406.29M · Polygon free float · Jul 31, 2026

10
Oct 15 (33d)prev 10– 0.0%
1.00
Oct 15 (33d)prev 1.00– 0.0%
Borrow (IBKR)

The cost to borrow AVCTF shares for a short sale and how many IBKR has available, from IBKR's lendable-stock file, refreshed through the session.

IBKR borrow fee and availability is included in Signal8 ProUpgrade to Pro · $40.67/mo billed annually
Off-exchange & settlement
100.0%
Nov 5 (12d)prev 100.0%– 0.0 pts

Off-exchange short volume is not short interest and is not a bearish signal. When a wholesaler fills a retail buy order it sells to the customer as principal and buys back in the market, and that sale is reported as short. A high reported short share is therefore characteristic of internalised retail buying, and this figure should not be read as investors positioning against the stock.

No fails on record for 16–31 Oct 2026.
Price, short interest & fails to deliver
Short interest · today's share basis19 settlements
Latest short interest settlements (today's share basis)
DateShares short
Oct 15, 202610 sh
Sep 30, 202610 sh
Jul 31, 202651.9K sh
Jul 15, 202651.9K sh
Jun 30, 202631.6K sh

The three panels share one date axis, so a point's position is its date; each has its own value axis. Short interest is plotted on today's share basis, so the line does not step where a split does.

Off-exchange short volume
Nov 5
Latest sessions
DateReported short
Nov 5, 2026100.0%
Oct 29, 2026100.0%
Sep 15, 202699.9%
Aug 20, 2026100.0%
Aug 11, 2026100.0%
5-session median 100.0%mean 100.0%range 99.9–100.0%

130 calendar days requested; 6 sessions published. FINRA reports this at T+1 to T+2, so the latest session is not today's.

Source: FINRA Reg SHO daily short volume, summed across the NASDAQ, NYSE and Consolidated trade reporting facilities. Covers off-exchange (over-the-counter) executions only; volume executed on an exchange is not included and is not reported short here.

Off-exchange short volume is not short interest and is not a bearish signal. When a wholesaler fills a retail buy order it sells to the customer as principal and buys back in the market, and that sale is reported as short. A high reported short share is therefore characteristic of internalised retail buying, and this figure should not be read as investors positioning against the stock.

ATS venues (dark pools)

FINRA's weekly alternative trading system (dark pool) volume for AVCTF: the share of off-exchange volume that traded on an ATS, and each venue by shares and trades.

The ATS venue breakdown is included in Signal8 ProUpgrade to Pro · $40.67/mo billed annually

As of the Oct 30, 2026 FINRA settlement, 234,775 AVCTF shares were sold short (0.06% of a 406.29M-share float, 999.99 days to cover).